Alberta Investment Management Corp Takes $5.48 Million Position in Inspire Medical Systems, Inc. $INSP

Key Points

• Alberta Investment Management Corp. initiated a $5.48 million position in Inspire Medical Systems, purchasing 122,900 shares, while institutional investors collectively held 94.91% of the company.
• Inspire reported quarterly EPS of $0.14, beating the $0.24 loss consensus, and revenue of $200.58 million, above expectations; however, revenue declined 7.6% year over year.
• Analyst sentiment remains mixed, with a consensus “Hold” rating and a $66.19 target price versus the stock’s reported $57.07 price; targets ranged from $39 to $62 among recent updates.

Alberta Investment Management Corp purchased a new position in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 122,900 shares of the company's stock, valued at approximately $5,483,000. Alberta Investment Management Corp owned 0.43% of Inspire Medical Systems at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Daiwa Securities Group Inc. lifted its stake in Inspire Medical Systems by 38.7% in the second quarter. Daiwa Securities Group Inc. now owns 466 shares of the company's stock valued at $60,000 after buying an additional 130 shares during the last quarter. State of Wyoming lifted its position in Inspire Medical Systems by 31.5% in the 4th quarter. State of Wyoming now owns 731 shares of the company's stock valued at $67,000 after purchasing an additional 175 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in Inspire Medical Systems by 84.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 449 shares of the company's stock valued at $42,000 after purchasing an additional 205 shares during the period. Apollon Wealth Management LLC boosted its stake in Inspire Medical Systems by 5.6% during the 1st quarter. Apollon Wealth Management LLC now owns 3,997 shares of the company's stock valued at $206,000 after purchasing an additional 212 shares during the period. Finally, Blair William & Co. IL boosted its stake in Inspire Medical Systems by 5.1% during the 3rd quarter. Blair William & Co. IL now owns 4,865 shares of the company's stock valued at $361,000 after purchasing an additional 234 shares during the period. Institutional investors own 94.91% of the company's stock.

Inspire Medical Systems Price Performance

NYSE INSP opened at $57.07 on Tuesday. Inspire Medical Systems, Inc. has a 12 month low of $38.91 and a 12 month high of $147.03. The firm has a market capitalization of $1.65 billion, a PE ratio of 12.35, a P/E/G ratio of 4.34 and a beta of 0.70. The company's 50 day simple moving average is $49.68 and its 200 day simple moving average is $53.10.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $0.14 EPS for the quarter, topping the consensus estimate of ($0.24) by $0.38. The firm had revenue of $200.58 million for the quarter, compared to analysts' expectations of $194.72 million. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%.The firm's quarterly revenue was down 7.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.45 earnings per share. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Sell-side analysts anticipate that Inspire Medical Systems, Inc. will post 1.24 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Jason P. Kelly sold 963 shares of the firm's stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $59.55, for a total transaction of $57,346.65. Following the completion of the transaction, the insider owned 18,985 shares in the company, valued at approximately $1,130,556.75. This trade represents a 4.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 2.20% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have commented on INSP shares. Robert W. Baird raised their price target on shares of Inspire Medical Systems from $54.00 to $59.00 and gave the company a "neutral" rating in a research note on Tuesday, August 4th. UBS Group initiated coverage on Inspire Medical Systems in a research report on Tuesday, July 28th. They set a "sell" rating and a $39.00 price objective for the company. Weiss Ratings reissued a "sell (d)" rating on shares of Inspire Medical Systems in a report on Monday, August 3rd. Truist Financial restated a "hold" rating and issued a $62.00 target price (up from $54.00) on shares of Inspire Medical Systems in a research report on Tuesday, August 4th. Finally, Freedom Capital raised Inspire Medical Systems to a "strong-buy" rating in a research note on Tuesday, June 30th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, twelve have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, Inspire Medical Systems presently has an average rating of "Hold" and a consensus price target of $66.19.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company's flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source